GoodRx Holdings, Inc. - Common Stock (GDRX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
GDRX on Nasdaq
Shares outstanding
98,685,316
Price per share
$2.71
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
117,322,426
Total reported value
$496,241,712
% of total 13F portfolios
0%
Share change
-3,032,887
Value change
-$16,421,159
Number of holders
155
Price from insider filings
$2.71
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of GoodRx Holdings, Inc. - Common Stock (GDRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FRANCISCO PARTNERS IV, L.P. 36% $288,375,283 60,078,184 Francisco Partners GP IV, L.P. 16 Mar 2025
Idea Men, LLC 29% -10% $207,188,021 -$33,600,000 43,164,171 -14% Idea Men, LLC 21 Mar 2025
VANGUARD GROUP INC 9.3% $38,947,048 9,207,340 The Vanguard Group 30 Sep 2025
Bezdek Trevor 5.2% $25,881,571 5,391,994 Trevor Bezdek 16 Dec 2024
Hirsch Douglas Joseph 5.2% $25,881,571 5,391,994 Douglas Joseph Hirsch 16 Dec 2024
AMERIPRISE FINANCIAL INC 4.3% $22,246,901 4,634,771 Ameriprise Financial, Inc. 31 Mar 2025
MILLENNIUM MANAGEMENT LLC 2.1% $10,496,971 2,186,869 Millennium Management LLC 31 Dec 2024

As of 30 Sep 2025, 155 institutional investors reported holding 117,322,426 shares of GoodRx Holdings, Inc. - Common Stock (GDRX). This represents 119% of the company’s total 98,685,316 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of GoodRx Holdings, Inc. - Common Stock (GDRX) together control 109% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Francisco Partners Management, LP 61% 60,078,184 0% 44% $254,130,718
VANGUARD GROUP INC 9.3% 9,207,340 +7.3% 0% $38,947,050
AMERIPRISE FINANCIAL INC 3.9% 3,885,159 -19% 0% $16,434,223
Silver Lake Group, L.L.C. 3.6% 3,532,276 0% 0.29% $14,941,527
RENAISSANCE TECHNOLOGIES LLC 3.5% 3,469,338 -3.6% 0.02% $14,675,300
Petrus Trust Company, LTA 3.1% 3,098,559 0% 1.4% $13,106,905
DIMENSIONAL FUND ADVISORS LP 2.5% 2,497,518 -0.01% 0% $10,564,799
LSV ASSET MANAGEMENT 2.4% 2,354,581 +517% 0.02% $9,960,000
BlackRock, Inc. 2% 1,971,689 +14% 0% $8,340,245
Technology Crossover Management X, Ltd. 1.7% 1,653,566 0% 0.59% $6,994,584
Rip Road Capital Partners LP 1.6% 1,610,768 0% 7.3% $6,813,549
Connor, Clark & Lunn Investment Management Ltd. 1.6% 1,586,097 -5.1% 0.02% $6,709,190
CITADEL ADVISORS LLC 1.6% 1,555,098 -4.2% 0.01% $6,578,065
LAKEWOOD CAPITAL MANAGEMENT, LP 1.5% 1,492,274 -64% 0.48% $6,312,319
STATE STREET CORP 1.5% 1,456,728 -0.98% 0% $6,161,959
GOLDMAN SACHS GROUP INC 1.3% 1,273,681 +339% 0% $5,387,671
PATHWAY CAPITAL MANAGEMENT, LP 1% 986,158 +69% 21% $4,171,448
GEODE CAPITAL MANAGEMENT, LLC 0.94% 929,935 -13% 0% $3,935,031
Pacer Advisors, Inc. 0.88% 871,520 0.01% $3,686,530
Universal- Beteiligungs- und Servicegesellschaft mbH 0.73% 717,660 0.01% $3,035,702
STIFEL FINANCIAL CORP 0.73% 716,493 +18% 0% $3,030,777
JACOBS LEVY EQUITY MANAGEMENT, INC 0.61% 602,905 -27% 0.01% $2,550,288
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.53% 527,270 +2% 0% $2,230,352
MOORE CAPITAL MANAGEMENT, LP 0.53% 524,051 0.04% $2,216,736
TWO SIGMA ADVISERS, LP 0.53% 521,600 -36% 0% $2,206,368

Institutional Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 331,554 $902,751 +$314,456 $2.71 12
2025 Q3 117,322,426 $496,241,712 -$16,421,159 $4.23 155
2025 Q2 120,458,255 $599,884,035 -$4,664,396 $4.98 176
2025 Q1 121,628,630 $536,393,039 -$65,698,797 $4.41 164
2024 Q4 135,968,354 $632,244,381 -$55,086,685 $4.65 164
2024 Q3 142,032,675 $985,856,098 +$68,387,395 $6.94 163
2024 Q2 131,725,500 $1,027,464,544 +$24,275,288 $7.80 161
2024 Q1 128,743,736 $913,896,618 -$90,749,328 $7.10 154
2023 Q4 141,637,249 $948,962,237 +$31,081,244 $6.70 138
2023 Q3 137,728,416 $775,404,583 +$22,462,538 $5.63 151
2023 Q2 133,773,340 $738,443,895 -$18,174,990 $5.52 142
2023 Q1 136,443,326 $852,764,205 +$5,540,468 $6.25 151
2022 Q4 135,872,173 $633,174,025 -$16,390,175 $4.66 153
2022 Q3 139,523,504 $651,663,220 -$76,552,465 $4.67 156
2022 Q2 154,602,951 $915,568,088 -$34,966,903 $5.92 152
2022 Q1 145,985,292 $2,821,832,723 -$467,032,693 $19.33 158
2021 Q4 152,652,179 $4,988,313,146 +$336,547,280 $32.68 203
2021 Q3 139,573,202 $5,725,100,634 -$84,091,429 $41.02 208
2021 Q2 57,223,135 $2,060,732,372 +$355,935,810 $36.01 190
2021 Q1 131,712,129 $5,139,356,421 +$168,916,078 $39.02 196
2020 Q4 127,079,191 $5,131,253,891 +$41,105,714 $40.34 184
2020 Q3 36,851,110 $2,049,308,578 +$2,048,509,583 $55.60 144
2020 Q2 2,367 $85,000 $35.91 1
2020 Q1 2,367 $85,000 $35.91 1
2019 Q4 2,367 $85,000 $35.91 1
2019 Q3 2,367 $85,000 $35.91 1
2019 Q2 2,367 $85,000 $35.91 1
2019 Q1 2,367 $85,000 $35.91 1